All NewsFDA BriefsOncology IconsSpecial ReportsVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision Medicine
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CME/CE
Case-Based Roundtable SeriesClinical TrialsPartnersPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
eNewsletterPrint Subscription
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2-Positive Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CME/CE
Advertisement

Evolving Approaches for HCC in the Molecular Medicine Era

home / precision-medicine / evolving-approaches-for-hcc-in-the-molecular-medicine-era

An in-depth discussion on the targeting of specific molecular pathways with newer, novel therapies to better manage patients with liver cancer.

Advertisement

Optimizing Care for Patients With Hepatocellular Carcinoma

EP. 1: Optimizing Care for Patients With Hepatocellular Carcinoma

Targeted Oncology
November 5th 2020

Watch


Hepatocellular Carcinoma Risk Stratification and Therapy

EP. 2: Hepatocellular Carcinoma Risk Stratification and Therapy

Targeted Oncology
November 5th 2020

Watch


Testing for Targetable Mutations in Hepatocellular Carcinoma

EP. 3: Testing for Targetable Mutations in Hepatocellular Carcinoma

Targeted Oncology
November 5th 2020

Watch


Targeting the VEGF Pathway in Hepatocellular Carcinoma

EP. 4: Targeting the VEGF Pathway in Hepatocellular Carcinoma

Targeted Oncology
November 5th 2020

Watch


HCC: VEGF TKI Data and Treatment Selection

EP. 5: HCC: VEGF TKI Data and Treatment Selection

Targeted Oncology
November 5th 2020

Watch


PD-1/PD-L1 Antibodies and VEGF Inhibitors in HCC

EP. 6: PD-1/PD-L1 Antibodies and VEGF Inhibitors in HCC

Targeted Oncology
November 5th 2020

Watch

Advertisement

Atezolizumab/Bevacizumab Data in Frontline HCC

EP. 7: Atezolizumab/Bevacizumab Data in Frontline HCC

Targeted Oncology
November 5th 2020

Watch


Atezolizumab/Bevacizumab for HCC: Toxicity Management

EP. 8: Atezolizumab/Bevacizumab for HCC: Toxicity Management

Targeted Oncology
November 5th 2020

Watch


Choosing Between VEGF TKIs for Frontline HCC Treatment

EP. 9: Choosing Between VEGF TKIs for Frontline HCC Treatment

Targeted Oncology
November 5th 2020

Watch


HCC Treatment After Previous I/O Therapy

EP. 10: HCC Treatment After Previous I/O Therapy

Targeted Oncology
November 5th 2020

Watch


Novel Combinations Under Study for HCC

EP. 11: Novel Combinations Under Study for HCC

Targeted Oncology
November 5th 2020

Watch


Exciting Targets Under Study in HCC

EP. 12: Exciting Targets Under Study in HCC

Targeted Oncology
November 5th 2020

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.